Robot-assisted stereotactic biopsy of pediatric brainstem and thalamic lesions.
Gupta M, Chan TM, Santiago-Dieppa DR, Yekula A, Sanchez CE, Elster JD, Crawford JR, Levy ML, Gonda DD. Robot-assisted stereotactic biopsy of pediatric brainstem and thalamic lesions. Journal Of Neurosurgery Pediatrics 2020, 27: 317-324. PMID: 33361479, DOI: 10.3171/2020.7.peds20373.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentBiopsyBrain NeoplasmsBrain StemBrain Stem NeoplasmsChildChild, PreschoolFemaleGliomaHematomaHumansImaging, Three-DimensionalMalePatient PositioningPredictive Value of TestsRetrospective StudiesRobotic Surgical ProceduresStereotaxic TechniquesThalamic DiseasesThalamusYoung AdultConceptsRobot-assisted biopsiesStereotactic biopsyPediatric brainstemThalamic lesionsLesional tissueMajor adverse outcomesLarge clinical seriesRady Children's HospitalBiopsy of tumorsDiagnostic success rateDeep midline structuresAsymptomatic hematomaCranial neuropathiesConsecutive patientsThalamic tumorsAdverse outcomesChildren's HospitalClinical seriesDiencephalic tumorsPermanent deficitsSurgeon preferenceInstitutional experienceRetrospective analysisBiopsyBrainstemMutations in KRT10 in epidermolytic acanthoma
Cheraghlou S, Atzmony L, Roy SF, McNiff JM, Choate KA. Mutations in KRT10 in epidermolytic acanthoma. Journal Of Cutaneous Pathology 2020, 47: 524-529. PMID: 32045015, PMCID: PMC7914398, DOI: 10.1111/cup.13664.Peer-Reviewed Original ResearchConceptsWhole-exome sequencingEpidermolytic acanthomaEpidermolytic hyperkeratosisHotspot mutationsCharacteristic histopathological patternEpidermolytic ichthyosisHistopathological patternsHistopathological analysisDiscovery cohortLesional tissueAdditional casesPolymerase chain reaction amplificationEpidermal degenerationChain reaction amplificationFragment length polymorphism analysisRestriction fragment length polymorphism analysisLength polymorphism analysisDermatosesIchthyosis bullosaAcanthomaKRT10Departmental archivesReaction amplificationIchthyosisPolymorphism analysisTreatment of Multiorgan Sarcoidosis With Tofacitinib
Damsky W, Young BD, Sloan B, Miller EJ, Obando JA, King B. Treatment of Multiorgan Sarcoidosis With Tofacitinib. ACR Open Rheumatology 2020, 2: 106-109. PMID: 31916703, PMCID: PMC7011417, DOI: 10.1002/acr2.11112.Peer-Reviewed Original ResearchMultiorgan sarcoidosisTumor necrosis factor α blockadeNecrosis factor α blockadeCutaneous sarcoidosis lesionsEfficacy of tofacitinibIdiopathic inflammatory disorderJanus kinase inhibitorRecalcitrant sarcoidosisΑ-blockadeClinical remissionSarcoidosis lesionsGranulomatous inflammationInflammatory disordersAvid lesionsLesional tissueSarcoidosisJanus kinase-signal transducerSingle patientJAK inhibitorsJAK inhibitionKinase-signal transducerTofacitinibKinase inhibitorsActivator of transcriptionInternal organs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply